Skip to main content
. 2024 Mar 27;14:7245. doi: 10.1038/s41598-024-57265-x

Table 3.

Spearman's correlation between TNFRs, eGFR, and clinical parameters in healthy subjects and patients with type 2 diabetes.

Variables Healthy subjects (n = 413) Diabetics (n = 292)
TNFR1 TNFR2 GFR-Cr GFR-CysC TNFR1 TNFR2 GFR-Cr GFR-CysC
Age 0.04 0.11* − 0.47*** − 0.33*** 0.14* 0.16** − 0.48*** − 0.31***
BMI 0.08 0.05 − 0.21*** − 0.04 0.17** 0.11 0.20*** − 0.05
Systolic BP 0.07 0.11* − 0.14** − 0.09 0.11 0.07 − 0.07 − 0.15*
Diastolic BP 0.03 0.08 − 0.16** − 0.07 0.05 0.04 0.09 0.09
HbA1c 0.06 0.03 − 0.18*** − 0.12* − 0.20*** − 0.25*** 0.17** 0.08
HDL-C − 0.04 0.03 − 0.01 − 0.02 − 0.08 − 0.13* − 0.10 − 0.19**
Non-HDL-C 0.04 0.05 − 0.23*** − 0.17*** 0.19** 0.13* 0.10 0.05
Uric acid 0.01 − 0.01 − 0.12* 0.13** 0.17** 0.14* − 0.17** 0.05
UACR − 0.004 0.02 0.11* − 0.20*** 0.38*** 0.25*** 0.13* − 0.10
eGFR-Cr − 0.10* − 0.10* − 0.18** − 0.19**
eGFR-CysC − 0.38*** − 0.35*** 0.19*** − 0.30*** − 0.28*** 0.31***
TNFR2 0.58*** 0.82***

Abbreviations used in this table are the same as in Table 1.

*p < 0.05, **p < 0.01, ***p < 0.001